Solgenics’ Delisting Risks Shareholder Value
John Cornford gives his opinions on Solgenics’ current plans to delist ahead of Friday’s vote.
John Cornford gives his opinions on Solgenics’ current plans to delist ahead of Friday’s vote.
It has been a tough year for investors in Scottish Mortgage with results to the end of March revealing an NAV total return well below the FTSE All-World benchmark.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
John Cornford takes a look at a promising early stage gold miner.
Mark Watson-Mitchell looks at Pantheon again after they announced their upcoming raise was heavily oversubscribed.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Central banks must tame inflation and maintain financial stability at the same time. That poses a dilemma, says Victor Hill.
It turns out that Goldfinger was lurking in the East, waiting to pump £95m into the ultra-luxury brand.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.